We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+26.52%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$537M
AUM Growth
-$72.8M
Cap. Flow
-$116M
Cap. Flow %
-21.68%
Top 10 Hldgs %
8.85%
Holding
430
New
151
Increased
31
Reduced
82
Closed
160

Top Sells

Rank Stock Value
1
AEHR icon
Aehr Test Systems
AEHR
+$5.57M
2
SKY icon
Champion Homes
SKY
+$5.47M
3
BOOT icon
Boot Barn
BOOT
+$5.08M
4
INVE icon
Identive
INVE
+$4.9M
5
PI icon
Impinj
PI
+$4.76M

Sector Composition

Rank Sector Weight
1 Industrials 17.67%
2 Healthcare 17.17%
3 Energy 16.86%
4 Technology 12.11%
5 Materials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
51
Clear Channel Outdoor Holdings
CCO
$1.23B
$2.9M 0.54%
+838,445
New +$2.85M
IMXI icon
52
International Money Express
IMXI
$367M
$2.88M 0.54%
+139,870
New +$2.4M
BXC icon
53
BlueLinx
BXC
$671M
$2.83M 0.53%
39,435
-24,841
-39% -$2.03M
SNEX icon
54
StoneX
SNEX
$8.05B
$2.83M 0.53%
+193,342
New +$2.69M
AAWW
55
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.81M 0.52%
32,589
-8,914
-21% -$732K
HRMY icon
56
Harmony Biosciences
HRMY
$2.26B
$2.79M 0.52%
+57,340
New +$2.34M
ROCC
57
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2.75M 0.51%
79,532
+551
+0.7% +$18K
USAK
58
DELISTED
USA Truck Inc
USAK
$2.74M 0.51%
133,061
+52,257
+65% +$1.14M
OVV icon
59
Ovintiv
OVV
$16.6B
$2.71M 0.51%
50,200
-2,630
-5% -$113K
SXC icon
60
SunCoke Energy
SXC
$815M
$2.7M 0.5%
+303,375
New +$2.39M
GOLD
61
Gold.com Inc
GOLD
$1.22B
$2.68M 0.5%
69,362
+482
+0.7% +$16.5K
TVTY
62
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.65M 0.49%
+82,494
New +$2.23M
BCRX icon
63
BioCryst Pharmaceuticals
BCRX
$2.38B
$2.65M 0.49%
+162,969
New +$2.61M
ACET icon
64
Adicet Bio
ACET
$74.2M
$2.63M 0.49%
+8,236
New +$1.89M
ISEE
65
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.62M 0.49%
155,778
-34,235
-18% -$506K
VYGR icon
66
Voyager Therapeutics
VYGR
$189M
$2.59M 0.48%
+339,497
New +$1.51M
FRO icon
67
Frontline
FRO
$8.81B
$2.58M 0.48%
+293,750
New +$2.33M
VRTV
68
DELISTED
VERITIV CORPORATION
VRTV
$2.54M 0.47%
19,010
-538
-3% -$58.6K
CTO
69
CTO Realty Growth
CTO
$817M
$2.5M 0.46%
+112,872
New +$2.33M
ARLO icon
70
Arlo Technologies
ARLO
$1.68B
$2.49M 0.46%
281,304
+65,240
+30% +$599K
IRT icon
71
Independence Realty Trust
IRT
$4B
$2.49M 0.46%
94,264
-11,794
-11% -$289K
ITCI
72
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.47M 0.46%
40,330
-2,074
-5% -$108K
CYTK icon
73
Cytokinetics
CYTK
$11B
$2.44M 0.45%
66,255
-41,743
-39% -$1.48M
PR
74
Permian Resources
PR
$17B
$2.44M 0.45%
+302,215
New +$2.39M
XPOF icon
75
Xponential Fitness
XPOF
$266M
$2.42M 0.45%
103,131
+29,065
+39% +$568K

Similar funds

EAM Investors's Q1 2022 Portfolio in Review

As of Q1 2022, EAM Investors held 430 positions worth $537M, down 12% from $610M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

EAM Investors withdrew a net $116M in Q1 2022, closing 160 positions and reducing 82 holdings. Its most notable exit was Aehr Test Systems, an estimated $5.57M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Energy.

Against the trend, EAM Investors opened a new position in Sierra Oncology, Inc. Common Stock worth $4.38M.

  • EAM Investors's largest Q1 2022 buy was Sierra Oncology, Inc. Common Stock: 136,692 shares worth $4.38M.
  • EAM Investors added most to Edgio, Inc. Common Stock in Q1 2022, an estimated $2.82M increase.
  • EAM Investors's biggest Q1 2022 reduction was Clearfield, cutting an estimated $2.4M.
  • EAM Investors fully exited Aehr Test Systems in Q1 2022, selling an estimated $5.57M.
  • EAM Investors's ten largest holdings make up 8.9% of its $537M portfolio in Q1 2022.
  • EAM Investors opened 151 new positions and closed 160 in Q1 2022.
  • EAM Investors's portfolio value fell 12% quarter-over-quarter to $537M.

Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.